What is Alto Neuroscience's net change in cash?

Alto Neuroscience (ANRO) reported net change in cash of $87.28M in Q1 2026.

How has Alto Neuroscience's net change in cash changed year-over-year?

Alto Neuroscience's net change in cash increased by 1267.6% year-over-year, from -$7.48M to $87.28M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Alto Neuroscience ANRO Net Change in Cash

Net Change in Cash at other companies

Xenon PharmaceuticalsXENE

$346.7M+1,431%

Acadia PharmaceuticalsACAD

$104.52M+203%

Rapport Therapeutics, Inc.RAPP

$25.41M+3,080%

Praxis Precision Medicines, Inc.PRAX

$179M+459%

MeiraGTx Holdings plcMGTX

$5.44M+115%

LBR

LB Pharmaceuticals Inc Common StockLBRX

$70.51M+2,340%

Other financials

Income statement

See full

Operating income-$27.1M-73.1%

Net income-$26.2M-73.0%

EPS (diluted)-$0.80-42.9%

Balance sheet

See full

Cash & equivalents$264.3M+63.9%

Total debt$20.9M-17.2%

Total equity$243.4M+75.0%

Total assets$276.3M+60.7%

Cash flow

See full

Operating cash flow-$27.1M-63.6%

CapEx$556.0K+2,217%

Free cash flow-$27.6M-66.7%

Valuation

See full

Market cap$887.88M+1,358%

Enterprise value$644.49M-958%

Returns & leverage

See full

Return on equity-38.9%+0.9pp

Debt / equity0.1×-0.1×

Current ratio20.5×-2.0×

Where this comes from

Reported directly by Alto Neuroscience in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Neuroscience's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alto Neuroscience's net change in cash?: Alto Neuroscience (ANRO) reported net change in cash of $87.28M in Q1 2026.
How has Alto Neuroscience's net change in cash changed year-over-year?: Alto Neuroscience's net change in cash increased by 1267.6% year-over-year, from -$7.48M to $87.28M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.